Article
Bortezomib-Induced Skin Eruption in Patient with Newly Diagnosed Multiple Myeloma under VRd Regime: A Case Report
2025-07-18
Abstract excerpt
<title>Abstract</title> <p>The proteasome inhibitor bortezomib is used to treat various hematological cancers. It is currently included in the standard of care for individuals receiving their first line treatment for a recently diagnosed multiple myeloma. Generally well tolerated, bortezomib has been linked to a number of side effects. In this instance, a reticular eruption that developed at the site of a subcuta...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6f42b415-3a39-5b75-94c3-93f933508e8a
- DOI
- 10.21203/rs.3.rs-7124847/v1
